๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Induced remission of malignant melanoma with actinomycin D. Immunologic implications

โœ Scribed by Frederick M. Golomb; Alex C. Solowey; Allen Postel; Stephen L. Gumport; Jane C. Wright


Book ID
102666092
Publisher
John Wiley and Sons
Year
1967
Tongue
English
Weight
630 KB
Volume
20
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II evaluation of dibromodulcitol a
โœ David A. Amato; Howard Bruckner; DuPont Guerry; Arlene Ash; Geoffrey Falkson; Er ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 418 KB

In this Eastern Cooperative Oncology Group (ECOG) phase II study, dibromodulcitol (DBD) and a combination of actinomycin D, hydroxyurea, and cyclophosphamide (AHC) were compared with methyl-CCNU, the current ECOG standard, in patients who had received no prior chemotherapy for disseminated malignant

Hyperthermic regional perfusion with mel
โœ H. Martijn; J. Oldhoff; H. Schraffordt Koops ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 443 KB

## Abstract From September 1969 through 1979, 68 patients with already locally metastasized malignant melanomas of the extremities were treated by hyperthermic regional perfusion and local excision(s). Of these, 53 patients could be evaluated after a followโ€up of at least 2 years: 31 had been perfu